| Product Name | MF | CAS | Details |
|---|
| lubiprostone | C20H32F2O5 | 333963-40-9 | Details |
| Trifluridine | C10H11F3N2O5 | 70-00-8 | Details |
| Choline Fenofibrate | C22H28ClNO5 | 856676-23-8 | Details |
| Levalbuterol hydrochloride | C13H22ClNO3 | 50293-90-8 | Details |
| SalbutaMon Hydrochloride | C13H20ClNO3 | 41489-89-8 | Details |
| Salbutamol | C13H21NO3 | 34391-04-3 | Details |
| Tafluprost | C25H34F2O5 | 209860-87-7 | Details |
| Edoxaban (TsOH salt) | C31H38ClN7O7S2 | 480449-71-6 | Details |
| evocalcet | C24H26N2O2 | 870964-67-3 | Details |
| tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate oxalate | C16H29N3O7 | 1210348-34-7 | Details |
| Cyclohexanecarboxamide, 4-bromo-3-hydroxy-N,N-dimethyl-, (1S,3S,4S)- | C9H16BrNO2 | 1629245-79-9 | Details |
| ZVPVPYWMFMUFEZ-UHFFFAOYSA-N | C35H42N4O5 | 909800-36-8 | Details |
| (1S,4S,5S)-4-Bromo-6-oxabicyclo[3.2.1]octan-7-one | C7H9BrO2 | 139893-81-5 | Details |
| (1S,3R,4R)-3-amino-4-hydroxy-N,N-dimethylcyclohexanecarboxamide | C9H18N2O2 | 929693-36-7 | Details |
| Cyclohexanecarboxamide, 3-amino-4-hydroxy-N,N-dimethyl-, hydrobromide (1:1), (1S,3R,4R)- | C9H18N2O2.BrH | 2964483-51-8 | Details |
| Carbamic acid, N-[[[(1R,2R,5S)-5-[(dimethylamino)carbonyl]-2-hydroxycyclohexyl]amino]sulfonyl]-, 1,1-dimethylethyl ester | C14H27N3O6S | 1629245-68-6 | Details |
| (1R,2R,4S)-2-[(tert-butoxycarbonyl)aMino]-4-[(diMethylaMino)carbonyl]cyclohexyl Methanesulfonate | C15H28N2O6S | 929693-31-2 | Details |
| (1S,3S,6R)-N,N-dimethyl-7-oxabicyclo[4.1.0]heptane-3-carboxamide | C9H15NO2 | 929693-35-6 | Details |
| Edoxaban Impurity 16 | C14H25N5O3 | 480450-69-9 | Details |
| carbamic acid, n-[(1r,2r,5s)-5-[(dimethylamino)carbonyl]-2-hydroxycyclohexyl]-, 1,1-dimethylethyl ester | C14H26N2O4 | 929693-30-1 | Details |
| Disalicylimide | C14H11NO4 | 1972-71-0 | Details |
| NA | Details |
| NA | Details |
| NA | Details |
| Deferasirox Isopropyl Ester | C24H21N3O4 | 1266741-29-0 | Details |
| NA | Details |
| 4H-1,3-Benzoxazin-4-one, 2-(5-chloro-2-hydroxyphenyl)- | C14H8ClNO3 | 24798-50-3 | Details |
| NA | Details |
| Platinum, diamminedihydroxy[2-(hydroxy-κO)acetato(2-)-κO]-, (OC-6-44)- | C2H6N2O5Pt | 103436-60-8 | Details |
| Deferasirox Methyl Ester | C22H17N3O4 | 1266741-05-2 | Details |
| Platinum(2+), diamminediaqua-, (SP-4-2)-, dinitrate | H6N3O5Pt+ | 52241-26-6 | Details |
| azanide: dihydroxy-oxo-azanium: platinum(+4) cation: dihydroxide | H8N5O5Pt2+ | 62048-58-2 | Details |
| 4H-1,3-Benzoxazin-4-one, 6-chloro-2-(2-hydroxyphenyl)- | C14H8ClNO3 | 26276-85-7 | Details |
| Platinum, diamminechloro(hydroxyacetato-O1)-, (SP-4-3)- (9CI) | C2H7ClN2O3Pt | 157176-10-8 | Details |
| 1,3,5-Triazin-2(1H)-one, 4-amino-1-(2-deoxy-α-D-erythro-pentofuranosyl)-3,6-dihydro- | C8H14N4O4 | 114522-17-7 | Details |
| Deferasirox | C21H15N3O4 | 201530-41-8 | Details |
| NA | Details |
| Platinum (II), diammineoxalato-, cis- | C2H4N2O4Pt | 41349-15-9 | Details |
| trans-Dichlorodiamineplatinum(II) | Cl2H4N2Pt | 14913-33-8 | Details |
| Deferasirox Ethyl Ester | C23H19N3O4 | 201530-79-2 | Details |
| Benzoic acid, 4-[5-(5-chloro-2-hydroxyphenyl)-3-(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]- | C21H14ClN3O4 | 1620154-59-7 | Details |
| Esomeprazole | C17H19N3O3S | 119141-88-7 | Details |
| 1,1-Cyclopropanedicarboxamide, N,N'-bis[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]- | C39H34N4O8 | 2439164-91-5 | Details |
| Ilaprazole | C19H18N4O2S | 172152-36-2 | Details |
| PeMetrexed EP IMpurity A | C21H23N5O6 | 869791-42-4 | Details |
| 2-Pyridinecarboxylic acid, 1,4-dihydro-5-methyl-4-oxo-1-[6-(1H-pyrrol-1-yl)-1H-benzimidazol-2-yl]- | C18H14N4O3 | 1508282-87-8 | Details |
| Pemetrexed Disodium | C20H22N5NaO6 | 150399-23-8 | Details |
| Palonosetron Hydrochloride | C19H25ClN2O | 135729-62-3 | Details |
| PeMetrexed EP IMpurity E | C20H21N5O6 | 182009-04-7 | Details |
| PALONOSETRON HCL | C19H24N2O | 135729-75-8 | Details |
| PeMetrexed EP IMpurity D | C25H28N6O9 | 144051-68-3 | Details |
| Cabozantinib impurity 26 | C28H25ClFN3O5 | 2840522-80-5 | Details |
| PeMetrexed EP IMpurity B | C40H40N10O13 | 1802552-04-0 | Details |
| PeMetrexed EP IMpurity C | C40H40N10O13 | 1802552-16-4 | Details |
| EsoMeprazole related substance H431/41 | C16H15N3O4 | 1227380-90-6 | Details |
| Deferasirox Impurity 8 | C21H15N3O4 | 201530-78-1 | Details |
| FG-4592 interMediate | C17H13NO4 | 1455091-10-7 | Details |
| Riociguat | C20H19FN8O2 | 625115-55-1 | Details |
| tert-butyl (1R,2S,5S)-2-aMino-5-(diMethylcarbaMoyl)cyclohexylcarbaMate | C14H27N3O3 | 365998-36-3 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||